What is KAP?
An introduction to Ketamine-Assisted Psychotherapy: what to expect, how it works, and how to find a verified practitioner.
Understanding Ketamine-Assisted Psychotherapy
Ketamine-Assisted Psychotherapy (KAP) is a breakthrough therapeutic approach that combines the medical administration of ketamine with psychotherapy. Unlike traditional talk therapy alone, KAP uses ketamine's unique pharmacological properties to rapidly alleviate symptoms of depression, anxiety, PTSD, and other mental health conditions, creating a fertile window of neuroplasticity for deep psychological work.
How Does KAP Work?
Ketamine acts on the NMDA receptors in the brain, leading to a surge in glutamate — a key neurotransmitter associated with learning and memory. This surge triggers the release of Brain-Derived Neurotrophic Factor (BDNF), which promotes the growth of new neural connections (neuroplasticity).
This biological reset often quietens the "Default Mode Network" — the part of the brain associated with rigid, ruminative thought patterns and the ego. With this network temporarily subdued, patients often experience:
The Three Phases of KAP
Preparation
Establishing safety, setting intentions, and building a trusting relationship with the therapist before the medicine session.
Journey
The experiential session where ketamine is administered (via lozenge, IM, or IV) under therapeutic supervision.
Integration
Making sense of the insights gained during the journey and translating them into lasting behavioral changes.
Educational Video: How Ketamine works for Depression
Yale Medicine: Exploring how ketamine can rapidly relieve symptoms of severe depression.
Is KAP Right For You?
KAP is often recommended for individuals suffering from treatment-resistant depression, severe anxiety, PTSD, or those who feel "stuck" in traditional talk therapy.
However, it is not for everyone. Contraindications include a history of psychosis, certain cardiovascular conditions, and active substance use disorders. A thorough medical and psychological intake protocol is required.
Sources & Evidence-Based Research
- Sanacora, G., et al. (2017). A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. JAMA Psychiatry. Provides psychiatric consensus on the rapid antidepressant effects and safety guidelines for clinical use.
- Dore, J., et al. (2019). Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes... Journal of Psychoactive Drugs. Demonstrates significant decreases in depression and anxiety through KAP across a large cross-practice clinical sample.
- National Institute of Mental Health (NIMH). Ongoing clinical neuroscience research supporting ketamine's action on the glutamate system and its role in promoting synaptic plasticity (neuroplasticity) in treatment-resistant depression.
- Krupitsky, E., et al. (2002). Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. Journal of Substance Abuse Treatment. An early foundational study showing ketamine's disruption of rigid patterns.
Disclaimer: Oregon Counselor Directory acts only as an informational resource. Psychiatric protocols and clinical research are continually evolving. We encourage consulting your medical provider and original peer-reviewed literature to inform health choices.
Ready to explore locally?
Find verified, licensed KAP providers in your Oregon city through the Oregon Counselor Directory.
Find a KAP Therapist